SSA
COGT icon

Schonfeld Strategic Advisors’s Cogent Biosciences COGT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Buy
169,113
+56,650
+50% +$1.98M 0.02% 550
2026
Q1 		$4.33M Buy
+112,463
New +$4.15M 0.03% 534
2025
Q2 		– Sell
-10,080
Closed -$60.4K – 2105
2025
Q1 		$60.4K Buy
10,080
+80
+0.8% +$627 ﹤0.01% 2062
2024
Q4 		$78K Buy
+10,000
New +$99.7K ﹤0.01% 1855
2024
Q1 		– Sell
-260,955
Closed -$1.53M – 2115
2023
Q4 		$1.53M Buy
260,955
+23,425
+10% +$180K 0.01% 890
2023
Q3 		$2.32M Buy
237,530
+39,805
+20% +$472K 0.02% 782
2023
Q2 		$2.34M Sell
197,725
-6,532
-3% -$74.9K 0.02% 701
2023
Q1 		$2.2M Sell
204,257
-1,143
-0.6% -$14.6K 0.02% 664
2022
Q4 		$2.37M Buy
205,400
+115,617
+129% +$1.43M 0.02% 756
2022
Q3 		$1.34M Sell
89,783
-118,817
-57% -$1.63M 0.01% 1091
2022
Q2 		$1.88M Sell
208,600
-32,700
-14% -$223K 0.02% 763
2022
Q1 		$1.81M Sell
241,300
-4,100
-2% -$28.6K 0.02% 779
2021
Q4 		$2.1M Sell
245,400
-26,800
-10% -$233K 0.02% 687
2021
Q3 		$2.29M Sell
272,200
-1,500
-0.5% -$11.5K 0.02% 671
2021
Q2 		$2.22M Buy
273,700
+68,990
+34% +$583K 0.02% 677
2021
Q1 		$1.8M Buy
204,710
+82,234
+67% +$792K 0.02% 698
2020
Q4 		$1.38M Buy
+122,476
New +$1.35M 0.02% 704
2018
Q2 		– Sell
-18,250
Closed -$811K – 793
2018
Q1 		$811K Buy
+18,250
New +$811K 0.06% 374

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Schonfeld Strategic Advisors's COGT Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Cogent Biosciences (COGT) stake by 50% in Q2 2026, buying an estimated $1.98M and bringing the position to 169,113 shares worth $6.54M. The position accounts for 0.02% of the portfolio, ranked #550.

Schonfeld Strategic Advisors first reported a position in COGT in Q1 2018 and has held it in 18 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Schonfeld Strategic Advisors held 169,113 shares of Cogent Biosciences worth $6.54M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 56,650 Cogent Biosciences shares in Q2 2026, an estimated $1.98M.
  • Cogent Biosciences made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #550 holding.
  • Schonfeld Strategic Advisors first reported a position in Cogent Biosciences in Q1 2018 and has held it in 18 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.